We’re transforming our culture and our organization to leverage the full diversity of our people at all levels. Because teams and leaders who reflect our communities are a source of strength, and a key ingredient of our success.
In the second year of our full-scale culture transformation, we launched a fleet of initiatives to fuel the passion of our people and reinvent the way we work, with DE&I as our North star.
Our DE&I strategy is now fully operationalized, shaped and driven by a first-of-its-kind in pharma DE&I Board and brought to life by employees. Three of the Board’s founding members are respected, external experts who advise and challenge us, sitting alongside members of our Executive Committee and ERGs. They hold us to account, ensure we act on our DE&I commitments, monitor progress on our 2025 goals, and advise on how to accelerate our impact.
> Hear from Dr. Rohini Anand, DE&I pioneer and renowned thought leader on first experiencing life as an outsider.
> Click to see award-winning social entrepreneur and founder of the Valuable 500, Caroline Casey, talking about her passion for ending disability inequality.
